Exact Mass: 399.05030980000004
Exact Mass Matches: 399.05030980000004
Found 103 metabolites which its exact mass value is equals to given mass value 399.05030980000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Timepidium bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent ATC code: A03AB19
Vitisidin A
Vitisidin A is a polyphenol compound found in foods of plant origin (PMID: 20428313). A polyphenol compound found in foods of plant origin (PhenolExplorer)
1H-Indole-2-carbonitrile, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-3-iodo-
N6-Monobutyryl-cAMP
Pantoprazole Sulfone
C16H15F2N3O5S (399.07004440000003)
R-4'-phosphopantothenoyl-L-cysteine
C12H20N2O9PS (399.0627100000001)
R-4-phosphopantothenoyl-l-cysteine is a member of the class of compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. R-4-phosphopantothenoyl-l-cysteine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). R-4-phosphopantothenoyl-l-cysteine can be found in a number of food items such as peach, chia, persian lime, and yellow pond-lily, which makes R-4-phosphopantothenoyl-l-cysteine a potential biomarker for the consumption of these food products.
3-Carbamoyl-acetyl-9-methyl-10-oxo-4,5,9-trihydroxy-9,10-dihydroanthracen-2-essigsaeure
gamma-Glutamylselenocystathionin II
C12H21N3O7Se (399.05446459999996)
7-[(2-Carboxy-1-pyrrolidinyl)methyl]-5,6-dihydroxy-2-methyl-4H-naphtho[2,3-b]pyran-4,8,9-trione
gamma-Glutamylselenocystathionin I
C12H21N3O7Se (399.05446459999996)
1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-
C16H15F2N3O5S (399.07004440000003)
Vitisidin A
6-BROMO-2-(3-ISOBUTOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
Rufloxacin hydrochloride
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors
5-(2,4-difluorophenyl)-2-(4-nitrobenzoyl)oxybenzoic acid
C20H11F2NO6 (399.05544100000003)
Triethylsulfonium bis(trifluoromethylsulfonyl)imide
C8H15F6NO4S3 (399.00673820000003)
Methyl 2-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylate
C17H16F3N3O3S (399.0864422000001)
Methyl 5-N,4-O-Carbonyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosylonate
C17H21NO8S (399.09878260000005)
4-(2,4-dichlorophenyl)-8-(trifluoromethoxy)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
1-ethyl-2-methylnaphtho[1,2-d]thiazolium toluene-p-sulphonate
C21H21NO3S2 (399.09627960000006)
2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide
4-Nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester
C18H13N3O6S (399.05250380000007)
[2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-iodophenyl]methanol
C16H18INOS (399.01538080000006)
1-[[2-(2,4-Dichlorophenoxy)-1-oxoethyl]amino]-3-(4-methoxyphenyl)thiourea
ethyl 2-[(4E)-1-acetyl-5-oxo-4-[[4-(1,2,4-triazol-1-yl)phenyl]methylidene]imidazol-2-yl]sulfanylacetate
C18H17N5O4S (399.10012020000005)
4-Methyl-3-nitrobenzoic acid [4-oxo-6-[(2-pyrimidinylthio)methyl]-3-pyranyl] ester
C18H13N3O6S (399.05250380000007)
4-(4-chlorophenyl)sulfonyl-N-(furan-2-ylmethyl)piperazine-1-carbothioamide
C16H18ClN3O3S2 (399.04780680000005)
(4-Bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone
(1R)-1-{[(4-Methoxy-1,1-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid
(1S)-1-{[(4-Methoxy-1,1-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid
8-bromo-1-[[4-(trifluoromethyl)phenyl]methyl]-5H-4,1-benzoxazepin-2-one
C17H13BrF3NO2 (399.00816940000004)
(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)
D000970 - Antineoplastic Agents
N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)
C12H20N2O9PS-3 (399.0627100000001)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[(2S,3S)-2,4,6,8-tetrahydroxy-5,10-dioxo-5,10-dihydroanthra[2,3-b]furan-3-yl]ethyl acetate
N-[[1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyindol-3-yl]methyl]carbamodithioate
2,4-Dichloro-5-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylbenzoyl)-3-methylphenolate
(2S)-2-amino-5-[[(2R)-3-[carboxy(chloro)methyl]sulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
C12H18ClN3O8S (399.05030980000004)
R-4-phosphopantothenoyl-L-cysteine
C12H20N2O9PS-3 (399.0627100000001)
Timepidium bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide
Ethyl 2-[(4-bromo-1-ethylpyrazole-3-carbonyl)amino]-4,5-dimethylthiophene-3-carboxylate
C15H18BrN3O3S (399.02521780000006)
N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[(3-methyl-2-imidazo[4,5-b]pyridinyl)thio]acetamide
(2S,3S)-versiconal hemiacetal acetate(1-)
A phenolate anion obtained by deprotonation of the 8-hydroxy group of (2S-3S)-versiconal hemiacetal acetate. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
2-chloro-N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]benzenesulfonamide
C17H19Cl2N3O2S (399.05749740000005)
2,4-difluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
4-[[[5-[(4-chlorophenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1H-quinolin-2-one
C19H14ClN3O3S (399.0444364000001)
2-(2-Chloro-6-fluoro-phenyl)-3-(4-methyl-6-phenyl-pyrimidin-2-yl)thiazolidin-4-one
C20H15ClFN3OS (399.06083420000004)
2,6-difluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
2-Acetyl-3,4a,8,10,11,12a-hexahydroxy-1,4,4a,5,12,12a-hexahydrotetracene-1,12-dione
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-2-methyl-1-piperazinyl]methanone
N-[(E)-(2-bromo-5-methoxyphenyl)methylideneamino]-N-hydroxyoctanediamide
C16H22BrN3O4 (399.07935920000006)
Ethyl 3-[(2-chlorophenyl)diazenyl]-2-methyl-4,5-dioxo-1-phenylpyrrolidine-2-carboxylate
C20H18ClN3O4 (399.09857780000004)
4-chloro-N-(4,5-dihydroxy-2-methyl-2,3,4,5-tetrahydroindol-1-yl)-3-sulfamoylbenzamide
C16H18ClN3O5S (399.06556480000006)
[5-[2-amino-5-(formamidomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
C13H14N5O8P-2 (399.05799740000003)
N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)
C12H20N2O9PS (399.0627100000001)
Trianion of N-[(R)-4-phosphopantothenoyl]-L-cysteine arising from deprotonation of carboxylic acid and phosphate functions.
NS3861 (fumarate)
C16H18BrNO4S (399.01398480000006)
NS3861 fumarate is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively[1].
(2r)-1-({5,6-dihydroxy-2-methyl-4,8,9-trioxocyclohexa[g]chromen-7-yl}methyl)pyrrolidine-2-carboxylic acid
3-{[3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-1-sulfanylpropylidene]amino}propanoic acid
(2s)-2-amino-4-{[(1r)-2-({[(r)-(2r)-2-amino-2-carboxyethanesulfinyl]methyl}sulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid
(2s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylbutanoic acid
2-amino-4-[(2-{[(2-amino-2-carboxyethanesulfinyl)methyl]sulfanyl}-1-carboxyethyl)-c-hydroxycarbonimidoyl]butanoic acid
(2s)-2-{[(1s)-3-{[(2r)-2-amino-2-carboxyethyl]selanyl}-1-carboxypropyl]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
C12H21N3O7Se (399.05446459999996)
(2s)-2-{[(1r)-2-{[(3s)-3-amino-3-carboxypropyl]selanyl}-1-carboxyethyl]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
C12H21N3O7Se (399.05446459999996)
(2s,5s)-5-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]pyrrolidine-2-carboxylic acid
2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylbutanoic acid
2-({3-[(2-amino-2-carboxyethyl)selanyl]-1-carboxypropyl}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
C12H21N3O7Se (399.05446459999996)
(2s,5r)-5-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]pyrrolidine-2-carboxylic acid
2-({2-[(3-amino-3-carboxypropyl)selanyl]-1-carboxyethyl}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
C12H21N3O7Se (399.05446459999996)